European Archives - Page 60 of 1136 - European Medical Journal

The word spotlight on a blue background

Spotlight: March 2025

From the latest news impacting the UK’s NHS to large industry acquisitions, March brought a range of impactful news.

Spoonful of technology: Jan-March 2025

Discover the latest pharma innovations, from needle-free vaccines to NHS data access and interactive case studies in medical education.

Rare Case of Flu-Linked Brain Inflammation Detected by PET/CT Scan

Scientists in China report a rare case of brain inflammation linked to influenza, diagnosed using a F-18 FDG-PET/CT scan.

COURAGE-ALS Trial: Reldesemtiv Fails to Slow ALS Progression

Reldesemtiv fails to slow ALS progression in COURAGE-ALS trial, highlighting challenges in ALS treatment development.

Stephen Chan

Onc Now: Episode 14: What Role Does Diet Play in Liver Cancer Prevention?

Stephen Chan, Clinical Professor at the Department of Clinical Oncology of the Chinese University of Hong Kong, shares new frontiers in liver cancer treatment.

Is Gestational Diabetes Risk Reduced by High Protein Diet?

New research shows that animal and total protein intake could reduce the risk of gestational diabetes during pregnancy.

Ultra-Processed Foods and Their Impact on Allergies and Health

While food additives play a crucial role in food preservation and enhancement, their potential long-term effects on immune and metabolic health remain a growing concern.

Microwave Ablation for Renal Cell Carcinoma

Microwave ablation is an effective treatment modality for T1a and selected T1b renal cell carcinoma (RCC). Independent of the type of…

Illustration of a heart with a monitor

Could gene therapy transform heart failure treatment?

A gene therapy for heart failure with preserved ejection fraction (HFpEF) has shown promising early results.

Enzyme Spikes During Hepatitis D Treatment May Indicate Viral Suppression

A Phase 2 clinical trial finds that ALT flares are common in hepatitis D patients treated with pegylated interferon-alpha, but pose no safety risk, and may even signal better viral response.